B. Burmeister

M. Ychou, C. V. D. van de Velde, P. Kienle, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.

M. Ychou, C. V. D. van de Velde, P. Kienle, 2013, European journal of cancer.

Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial.

A. Barbour, D. Gotley, B. Smithers, 2011, European journal of cancer.

Refining Esophageal Cancer Staging After Neoadjuvant Therapy: Importance of Treatment Response

M. Gonen, A. Barbour, D. Gotley, 2008, Annals of Surgical Oncology.

Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy

D. Gotley, B. Smithers, B. Burmeister, 2004, The British journal of surgery.

Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia.

D. Gotley, E. Beller, B. Smithers, 2004, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

A combined modality approach to the management of oesophageal cancer.

P. Devitt, D. Gotley, D. Joseph, 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma.

M. Poulsen, S. Porceddu, B. Burmeister, 2011, Oral oncology.

A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer

B. Smithers, B. Burmeister, E. Burmeister, 2009, Investigational New Drugs.

Chemoradiation for inoperable non small cell lung cancer: a phase II study using a regimen with acceptable toxicity.

W. Kelly, B. Burmeister, N. Gogna, 1999, Lung cancer.

Hypofractionated Whole‐Breast Radiotherapy: Impact on Departmental Waiting Times and Cost

B. Hickey, B. Burmeister, E. Burmeister, 2010, Journal of medical imaging and radiation oncology.

A randomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: An intergroup trial (TROG, AGITG, CSSANZ, RACS).

Trog, R. Fisher, D. Goldstein, 2010 .

The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04).

D. Goldstein, J. Zalcberg, R. Fisher, 2016, European journal of cancer.

Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group.

R. Fisher, D. Goldstein, D. Joseph, 2001, International journal of radiation oncology, biology, physics.

The changing role of radiation therapy in the management of rectal cancer.

B. Burmeister, 2000, The Australian and New Zealand journal of surgery.

An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection

A. Barbour, D. Lambie, M. Foote, 2012, Melanoma research.

Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.

D. Goldstein, J. Zalcberg, D. Joseph, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improving the therapeutic ratio in non-operable oesophageal cancer.

B. Burmeister, 2014, The Lancet. Oncology.

Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study.

P. Devitt, S. Ackland, N. Spry, 1995, International journal of radiation oncology, biology, physics.

Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy.

A. Barbour, D. Gotley, B. Smithers, 2007, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials.

M. Ychou, C. V. D. van de Velde, M. Kieser, 2019, European journal of cancer.

Risk Profiles for Sensorineural Hearing Loss in Patients with Head and Neck Cancer Receiving Cisplatin-based Chemoradiation.

K. Mengersen, F. Harden, B. Panizza, 2017, Journal of medical imaging and radiation sciences.

Individual patient data meta-analysis of neoadjuvant chemotherapy followed by surgery versus upfront surgery for carcinoma of the oesophagus or the gastro-oesophageal junction.

V. Gebski, J. Roth, Jian-Hua Fu, 2021, European journal of cancer.

Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experience

P. Gibbs, D. Goldstein, C. Karapetis, 2004, ANZ journal of surgery.

Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: a direct and adjusted indirect comparison meta-analysis.

M. Mauer, L. Lundell, K. Kumagai, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Feasibility of chemoradiation therapy with protracted infusion of5-fluorouracil for esophageal cancer patients not suitable for cisplatin

D. Gotley, B. Smithers, B. Burmeister, 2005, International Journal of Clinical Oncology.

Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG‐PET‐‐guided neck management policy

B. Panizza, M. Foote, S. Porceddu, 2014, Head & neck.

T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.

B. Panizza, M. Foote, B. Burmeister, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

RE: A phase I trial of radiation dose escalation using accelerated concomitant boost radiotherapy concurrently with weekly carboplatin/paclitaxel in patients with good performance status and Stage IIB‐IIIA/B non‐small cell lung cancer

B. Burmeister, M. Lehman, K. Horwood, 2012, Journal of medical imaging and radiation oncology.

Stage Is Not a Reliable Indicator of Tumor Volume in Non-small Cell Lung Cancer: A Preliminary Analysis of the Trans-Tasman Radiation Oncology Group 99-05 Database

R. Fisher, S. Vinod, D. Joseph, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy.

B. Panizza, M. Foote, S. Porceddu, 2015, Oral oncology.

Esophagus Carcinoma Surveillance Counterpoint: Australia

B. Smithers, B. Burmeister, Janine M. Thomas, 2013 .

Preservation of Form and Function in the Management of Head and Neck Skin Cancer

M. Poulsen, B. Burmeister, D. Kennedy, 2003, World journal of surgery.

Second primary oesophageal cancer following radiation for breast cancer.

D. Gotley, B. Smithers, B. Burmeister, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

External beam radiation therapy as an agent in the aetiology of carcinoma of the bile duct: a report on two patients.

B. Burmeister, S. Turner, 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework

V. Gebski, T. Kron, B. Burmeister, 2015, Journal of medical imaging and radiation oncology.

Targeted therapy and chemoradiotherapy in oesophageal cancer.

S. Porceddu, B. Burmeister, 2013, The Lancet. Oncology.

3008 ORAL Acute adverse events in a randomised trial of short course versus long course preoperative radiotherapy for T3 adenocarcinoma of rectum: a Trans-Tasman Radiation Oncology Group trial (TROG 01.04)

R. Fisher, D. Goldstein, D. Joseph, 2007 .

Quality assurance experience with the randomized neuropathic bone pain trial (Trans-Tasman Radiation Oncology Group, 96.05).

P. Hoskin, D. Ball, N. Spry, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized resectable cancer of the esophagus

V. Gebski, P. Devitt, D. Joseph, 2002 .

Causes for increased myelosuppression with increasing age in patients with oesophageal cancer treated by chemoradiotherapy.

S. Ackland, N. Spry, B. Burmeister, 1999, European journal of cancer.

Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: Results of an intergroup randomized trial (ANZMTG 01.02/TROG 02.01).

R. Fisher, K. Shannon, R. Scolyer, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation therapy for the management of localized prostate carcinoma.

B. Burmeister, J. Probert, 1991, The Australian and New Zealand journal of surgery.

Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05).

N. Spry, B. Burmeister, D. Roos, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Patterns of Failure Following Dose-escalated Chemoradiotherapy for Fluorodeoxyglucose Positron Emission Tomography Staged Squamous Cell Carcinoma of the Oesophagus.

A. Barbour, B. Smithers, B. Burmeister, 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.

R. Fisher, K. Shannon, R. Scolyer, 2015, The Lancet. Oncology.

A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series

M. Foote, B. Burmeister, Janine M. Thomas, 2010, Melanoma research.

Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial.

R. Scolyer, L. Haydu, G. Long, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Debate: adjuvant whole brain radiotherapy or not? More data is the wiser choice

S. Lo, A. Hong, G. Fogarty, 2016, BMC Cancer.

Primary Cardiac Angiosarcoma: a Case Report and Review of the Literature on Utility of Advanced Imaging Techniques and Choice of Therapy

B. Burmeister, M. Thu, M. Stephens, 2016 .

A phase I study of moderate-dose radiation therapy and weekly gemcitabine in patients with locally advanced non-small cell lung cancer not suitable for radical chemoradiation therapy.

D. Fielding, J. Ramsay, B. Burmeister, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Two cases of esophageal carcinoma following corrosive esophagitis successfully treated with chemoradiation therapy

B. Smithers, B. Burmeister, E. Walpole, 2007 .

Concurrent chemoradiation for oesophageal cancer: factors influencing myelotoxicity.

B. Burmeister, J. Denham, D. Lamb, 1996, Australasian radiology.

Factors influencing outcome following radio-chemotherapy for oesophageal cancer

D. Joseph, N. Spry, B. Burmeister, 1996 .

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors' reply

B. Smithers, B. Burmeister, 2005 .

Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of Life

R. Fisher, K. Shannon, R. Scolyer, 2019, Annals of Surgical Oncology.

Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.

R. Fisher, K. Shannon, R. Scolyer, 2012, The Lancet. Oncology.

T1-2 anal carcinoma requires elective inguinal radiation treatment--the results of Trans Tasman Radiation Oncology Group study TROG 99.02.

D. Joseph, N. Spry, B. Burmeister, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Sensorineural hearing loss: Who is most at risk and what can we do about it?

F. Harden, M. Foote, B. Burmeister, 2014 .

Combined modality therapy for carcinoma of the oesophagus: current status and future directions

B. Smithers, B. Burmeister, J. Denham, 1997, The Medical journal of Australia.

Phase I trial of gefitinib (ZD1839) in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non-small cell lung cancer.

D. Ball, D. Rischin, M. MacManus, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality

R. Scolyer, H. Dhillon, A. Hong, 2015, BMC Research Notes.

Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible

L. Haydu, A. Hong, G. Fogarty, 2014, BMC Research Notes.

Melanoma brain metastases: the impact of nodal disease

B. Smithers, M. Foote, B. Smithers, 2012, Clinical & Experimental Metastasis.

Adjuvant external beam radiotherapy after therapeutic groin lymphadenectomy for patients with melanoma: a dosimetric comparison of three-dimensional conformal and intensity-modulated radiotherapy techniques

M. Foote, B. Burmeister, G. Adams, 2017, Melanoma research.

Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG)

D. Joseph, N. Spry, B. Burmeister, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase I trial of gefitinib in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non small cell lung cancer (“CRITICAL”): P2-162

D. Ball, B. Burmeister, M. Boyer, 2007 .

Radiation therapy for nodal disease in malignant melanoma

B. Smithers, M. Poulsen, B. Burmeister, 1995, World journal of surgery.

The management of metastases to eye and orbit from carcinoma of the breast.

W. J. Childs, B. Burmeister, C. Benjamin, 1990, Australian and New Zealand journal of ophthalmology.

An Ex Vivo Human Tumor Assay Shows Distinct Patterns of EGFR Trafficking in Squamous Cell Carcinoma Correlating to Therapeutic Outcomes.

H. Soyer, I. Frazer, Shannon R. Joseph, 2019, The Journal of investigative dermatology.

Scientific Exhibits

M. Foote, B. Burmeister, A. Kamiński, 2014 .

4–7 September 2014

M. Foote, B. Burmeister, A. Kamiński, 2014, Journal of medical radiation sciences.

The ENHANCES study—Enhancing Head and Neck Cancer patients’ Experiences of Survivorship: study protocol for a randomized controlled trial

A. McCarthy, P. Yates, H. Skerman, 2014, Trials.

BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy.

K. Dutton-Regester, N. Hayward, L. Krause, 2014, European journal of cancer.

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

V. Gebski, R. Simes, R. Simes, 2005, The Lancet. Oncology.

Economic analysis of FDG‐PET–guided management of the neck after primary chemoradiotherapy for node‐positive head and neck squamous cell carcinoma

P. Scuffham, J. Whitty, S. Porceddu, 2013, Head & neck.

Intra-operative implant brachytherapy in the management of soft-tissue sarcomas.

B. Burmeister, I. Dickinson, G. Bryant, 1997, The Australian and New Zealand journal of surgery.

Chapter 42 – Malignant Melanoma

M. Ballo, B. Burmeister, 2016 .

Neurotropic Melanoma: The Management of Localised Disease

M. Foote, B. Burmeister, J. Croker, 2012, Journal of skin cancer.

DESMOPLASTIC MELANOMA: THE ROLE OF RADIOTHERAPY IN IMPROVING LOCAL CONTROL

M. Foote, B. Smithers, B. Burmeister, 2008, ANZ journal of surgery.

Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus.

D. Gotley, B. Smithers, B. Burmeister, 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma

M. Shackleton, R. Wolfe, M. Carlino, 2021, Clinical and translational radiation oncology.

A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases.

N. Spry, M. Poulsen, B. Burmeister, 2003, Australasian radiology.

Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population

J. Fleming, T. Haines, S. Bennett, 2010, Supportive Care in Cancer.

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06.

N. Spry, B. Burmeister, Carol Johnson, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation therapy following nodal surgery for melanoma: An analysis of late toxicity

B. Smithers, N. Spry, B. Smithers, 2002, ANZ journal of surgery.

Radiotherapy for metastatic melanoma presenting in pregnancy.

B. Smithers, B. Burmeister, A. Kane, 2006, Australasian radiology.

Results of a phase II, open‐label, non‐comparative study of intralesional PV‐10 followed by radiotherapy for the treatment of in‐transit or metastatic melanoma

B. Smithers, T. Read, M. Wagels, 2017, Journal of surgical oncology.

Radiotherapy utilization in BRAF mutation‐tested metastatic melanoma in the targeted therapy era

M. Foote, B. Burmeister, V. Atkinson, 2015, Asia-Pacific journal of clinical oncology.

Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial

H. Dhillon, A. Hong, G. Fogarty, 2011, BMC Cancer.

Lung cancer patients in Queensland suffer delays in receiving radiation therapy – but not as a result of distance

B. Burmeister, E. Burmeister, E. Walpole, 2010, Internal medicine journal.

Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?

A. Barbour, M. Foote, B. Burmeister, 2015, Annals of surgical oncology.

Adjuvant external beam radiotherapy after therapeutic groin lymphadenectomy for patients at risk of nodal relapse: A dosimetric comparison of three-dimensional conformal and intensity modulated techniques

M. Foote, B. Burmeister, E. Burmeister, 2014 .

Stage III melanoma in the axilla: patterns of regional recurrence after surgery with and without adjuvant radiation therapy.

M. Foote, B. Smithers, B. Burmeister, 2013, International journal of radiation oncology, biology, physics.

Adjuvant nodal irradiation in melanoma – Authors' reply

M. Henderson, B. Burmeister, J. Thompson, 2012 .

Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: Results of an intergroup randomized trial (ANZMTG 01.02/TROG 02.01).

R. Fisher, K. Shannon, R. Scolyer, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality

R. Scolyer, H. Dhillon, A. Hong, 2015, BMC Research Notes.

Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible

L. Haydu, A. Hong, G. Fogarty, 2014, BMC Research Notes.

Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer.

M. Poulsen, S. Porceddu, B. Burmeister, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A phase 2 study of intralesional PV-10 followed by radiotherapy for localized in transit or recurrent metastatic melanoma.

T. Read, M. Foote, B. Smithers, 2016 .

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan

R. Scolyer, L. Haydu, H. Dhillon, 2019, Trials.

Relapse patterns after chemo-radiation for carcinoma of the oesophagus.

D. Joseph, S. Ackland, B. Smithers, 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

Epithelial-myoepithelial carcinoma of the tongue base: a case for the case-report and review of the literature

Patrick Stark, B. Burmeister, C. Repanos, 2010, Head & neck oncology.

Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05).

P. Hoskin, D. Ball, N. Spry, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A role for radiotherapy in neuropathic bone pain: preliminary response rates from a prospective trial (Trans-tasman radiation oncology group, TROG 96.05)

P. Hoskin, N. Spry, B. Burmeister, 2000, International journal of radiation oncology, biology, physics.

4–7 September 2014

M. Foote, B. Burmeister, A. Kamiński, 2014, Journal of Medical Radiation Sciences.

Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module

A. Bottomley, M. King, L. V. van de Poll-Franse, 2015, Melanoma research.

A Randomized Phase II Trial of Two Regimens of Moderate Dose Chemoradiation Therapy for Patients with Non-small Cell Lung Cancer Not Suitable for Curative Therapy: Trans Tasman Radiation Oncology Study TROG 03.07

G. Sasso, D. Ball, M. Michael, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Randomized Phase II Trial of Two Regimens of Moderate Dose Chemoradiation Therapy for Patients with Non-small Cell Lung Cancer Not Suitable for Curative Therapy

G. Sasso, D. Ball, M. Michael, 2011 .

The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: a prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05).

Shalini K Vinod, S. Vinod, D. Joseph, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Results of a prospective study of PET-directed management of the neck in node positive head and neck cancer following definitive radiotherapy with or without systemic therapy

B. Panizza, M. Foote, M. Poulsen, 2010 .

Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond.

R. Hicks, S. Porceddu, B. Burmeister, 2008, Hematology/oncology clinics of North America.

International practice survey on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom control.

A. Bezjak, G. Rodrigues, B. Movsas, 2010, Clinical lung cancer.

Consensus statement on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom control.

A. Bezjak, G. Rodrigues, B. Movsas, 2012, Clinical lung cancer.

Salvage definitive chemo‐radiotherapy for locally recurrent oesophageal carcinoma after primary surgery: Retrospective review

J. Harvey, B. Burmeister, M. Smithers, 2008, Journal of medical imaging and radiation oncology.

A comparison of quality of life in patients with T3 rectal cancer receiving short course versus long course preoperative radiation. A Trans-Tasman Radiation Oncology Group Trial (TROG 01.04)

R. Fisher, B. Burmeister, M. Solomon, 2008 .

The ENHANCES study: a randomised controlled trial of a nurse-led survivorship intervention for patients treated for head and neck cancer

A. McCarthy, P. Yates, H. Skerman, 2019, Supportive Care in Cancer.

Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy.

B. Smithers, B. Burmeister, K. Morton, 2000, Archives of otolaryngology--head & neck surgery.

Primary non-Hodgkins lymphoma of bone (case report).

B. Burmeister, C. Benjamin, 1989, Australasian radiology.

Synchronous postoperative adjuvant chemoradiation therapy for locally advanced carcinoma of the rectum

M. Poulsen, B. Burmeister, E. Burmeister, 2003, International Journal of Colorectal Disease.

Melanoma brain metastases: the impact of nodal disease

M. Foote, B. Smithers, B. Burmeister, 2012, Clinical & Experimental Metastasis.

Technique and early clinical outcomes for spinal and paraspinal tumours treated with stereotactic body radiotherapy

M. Foote, B. Burmeister, A. Pullar, 2015, Journal of Clinical Neuroscience.

Inter‐ and intra‐fraction motion in stereotactic body radiotherapy for spinal and paraspinal tumours using cone‐beam CT and positional correction in six degrees of freedom

M. Foote, B. Burmeister, A. Pullar, 2016, Journal of medical imaging and radiation oncology.

Development of the Melanoma Concerns Questionnaire (MCQ‐28); refinement of the EORTC QLQ‐MEL38 module

R. Saw, F. Boyle, B. Burmeister, 2020, Psycho-oncology.

Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial

T. Ahmed, S. Lo, A. Hong, 2023, Clinical and translational radiation oncology.

Promising Results of a Cooperative Group Phase II Trial of Preoperative Chemoradiation for Locally Advanced Rectal Cancer (TROG 9801)

D. Goldstein, D. Joseph, R. Fisher, 2005, Diseases of the colon and rectum.

Is education an effective management strategy for reducing cancer-related fatigue?

J. Fleming, T. Haines, S. Bennett, 2011, Supportive Care in Cancer.

A multidimensional examination of correlates of fatigue during radiotherapy

J. Fleming, T. Haines, S. Bennett, 2010, Cancer.

Half body irradiation for the palliation of bone metastases.

B. Burmeister, J. Probert, 1990, Australasian Radiology.

Adjuvant Radiotherapy Improves Regional (Lymph Node Field) Control in Melanoma Patients after Lymphadenectomy

R. Fisher, H. Hoekstra, A. Hong, 2009 .

Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma

V. Gebski, J. Pignon, P. Schlag, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus

A. Barbour, D. Gotley, B. Smithers, 2018, Journal of surgical oncology.

Debate: adjuvant whole brain radiotherapy or not? More data is the wiser choice

S. Lo, A. Hong, G. Fogarty, 2016, BMC Cancer.

Malignant Broncho-Oesophageal Fistula following Radiotherapy for Noninvasive T3 Oesophageal Squamous Cell Carcinoma

B. Burmeister, Dwayne Reading, 2022, Case Reports in Gastroenterology.

Localization of small esophageal cancers for radiation planning using endoscopic contrast injection: report on a series of eight cases.

D. Gotley, B. Smithers, B. Burmeister, 2001, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

D. Goldstein, J. Zalcberg, D. Joseph, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recent advances in managing non-small-cell lung cancer: 3. Radiation therapy.

D. Ball, B. Burmeister, 1997, The Medical journal of Australia.

A novel ATM‐dependent checkpoint defect distinct from loss of function mutation promotes genomic instability in melanoma

S. Pavey, B. Gabrielli, B. Burmeister, 2016, Pigment cell & melanoma research.